Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 724.53M P/E - EPS this Y 86.70% Ern Qtrly Grth -
Income -545.06M Forward P/E -4.69 EPS next Y 94.40% 50D Avg Chg 7.00%
Sales 983.71M PEG 0.08 EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book N/A EPS next 5Y -69.60% 52W High Chg -87.00%
Recommedations 2.70 Quick Ratio 0.53 Shares Outstanding 139.95M 52W Low Chg 50.00%
Insider Own 4.99% ROA -17.02% Shares Float 123.70M Beta 1.60
Inst Own 57.43% ROE - Shares Shorted/Prior 43.77M/48.13M Price 8.40
Gross Margin -9.63% Profit Margin -55.41% Avg. Volume 6,289,924 Target Price 15.40
Oper. Margin -63.01% Earnings Date May 7 Volume 6,171,024 Change -4.06%
About Novavax, Inc.

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax, Inc. News
04/22/24 How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
04/21/24 These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
04/19/24 12 Most Shorted Stocks in 2024
04/15/24 Shah Capital nominates two highly qualified independent director candidates for Novavax
04/14/24 UPDATE 4-Novavax investor Shah Capital pushes for board shakeup
04/13/24 Better Buy: Bluebird Bio Vs. Novavax
04/12/24 Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
04/11/24 Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
04/09/24 Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
04/03/24 Ex-Pharma Executive and Cousin Admit to Insider Trading of Kodak
04/03/24 Why Investors Need to Take Advantage of These 2 Medical Stocks Now
04/02/24 1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague
04/01/24 Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
03/29/24 Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
11:24 AM Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
03/09/24 1 Beaten-Down Stock That's Still Not Worth Buying
03/07/24 7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
03/07/24 Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
03/06/24 The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
03/05/24 It’s Time! 3 Failing Biotech Stocks to Sell Right Now
NVAX Chatroom

User Image traditionalpurple Posted - 3 minutes ago

$NVAX 8k filed what Fu

User Image TrollingST Posted - 3 hours ago

$NVAX Next two weeks we should see volatility up ahead. Not that it's anything new for us but PFE earnings are on May 1st and MRNA earnings on May 2nd. Ours are listed between May 7th to May 12th. I'm assuming it'll be on May 7th, 8th, or 9th since we don't usually do earnings on Mondays or Fridays.

User Image e0fknu2k Posted - 3 hours ago

$NVAX What are they smoking? H5N1 vaccine for the chicken or for people?

User Image JRBWare Posted - 3 hours ago

$NVAX Just checking in. Looked on Twitter too. China Virus is still a thing? Who knew??? Looks like people in the UK are all excited about it for some reason.

User Image cayenne Posted - 4 hours ago

$NVAX $APLD $CYN Bulls have a spectacular weekend! Long&Strong!

User Image TrollingST Posted - 5 hours ago

$NVAX Incase anyone's left wondering why it dropped to 3.96 it was again done with about 5k shares. Most between $4 to 4.07.

User Image WhosYourDaddy_ Posted - 5 hours ago

$NVAX JJ's step mom Got bird flu. This should go up to $4.24 # #WEFeCKENSUCK #100%Ascam #JJsuckBIGblack🥒

User Image tatanka9 Posted - 5 hours ago

$NVAX For a bio company that positions itself as a world leader in Vaccine this company is so far behind???

User Image stockflippper Posted - 6 hours ago

$NVAX We are happy to help! https://www.linkedin.com/posts/novavax_the-world-health-organization-today-recommended-activity-7189693286767316992-zMEb?utm_source=share&utm_medium=member_ios

User Image nano_cap Posted - 6 hours ago

$NVAX https://ottawacitizen.com/news/local-news/canadian-officials-considering-pre-pandemic-vaccines-as-bird-flu-spreads-through-u-s-livestock

User Image TrollingST Posted - 7 hours ago

$NVAX This can sort of look like our chart from where we're at now. Look at the post below and that's a possibility when everything looks like it's over, a new cycle begins. Just matter where you bought and where you'll sell. Again it's a possibility if you're an investor and not a trader.

User Image Inu007 Posted - 7 hours ago

$NVAX all good news why 3% not 30? Shah?!!!

User Image e0fknu2k Posted - 8 hours ago

$NVAX Time for a beer and have a good weekend everybody!

User Image Ochaye Posted - 8 hours ago

$NVAX Geeziz. Turns out they ain't even vaccines: https://www.youtube.com/watch?v=nbh_NB6LNaI&t=2338s

User Image TrollingST Posted - 8 hours ago

$NVAX Anyone care to figure this out? Seems like fintel got the 8k before Novavax filed on their PR. https://fintel.io/doc/sec-novavax-inc-1000694-8k-2024-april-26-19839-1924

User Image StarLord13 Posted - 9 hours ago

$NVAX Don’t give me that eod sell off!

User Image Crivit Posted - 9 hours ago

$NVAX https://www.who.int/news/item/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines

User Image nevermind889 Posted - 9 hours ago

$NVAX $IBRX One day!!

User Image TurdSniper Posted - 9 hours ago

$NVAX Do people really think the bird flu is gonna get this stock moving?

User Image TrollingST Posted - 10 hours ago

$NVAX Do your fucking part people. Man up and stop bitching. Sold some crypto and got $2000 to buy 465 more shares. Fuck these crooks.

User Image MaverikIT Posted - 10 hours ago

@IsabellaDC @DonCorleone77 @net0trader @Wigglyick @RonIsWrong @Im_not_Mr_Lebowski @Cash4freedom $NVAX - too little too late - double 'middle' fingers

User Image TrollingST Posted - 10 hours ago

$NVAX Any other stock would be up 20% just on this news alone. There's not even much options for today so there's really nothing holding it back other than the 43 million pound short gorilla on our backs. So clinging to it's short position this market maker.

User Image BTC321 Posted - 10 hours ago

$NVAX https://ir.novavax.com/press-releases/Novavax-Prepared-to-Deliver-Protein-based-Non-mRNA-JN-1-COVID-19-Vaccine-in-Line-with-WHO-Recommendation-this-Fall

User Image wamomo Posted - 10 hours ago

$NVAX although, I would have liked to see a massive capitulation to mark the low price and start a massive short squeeze, I will settle for a slow and steady climb as indicated by the shrinking of the number of short shares. They managed to cover about 8 million shares without driving the price up. This tells me that they are professionals; likely hedge funds who were short. As long as they go long now, is all I care about... let's go

User Image StarLord13 Posted - 10 hours ago

$NVAX Higher low with a golden cross on the daily 50 and 100ma. Weekly stochastic inverting back up 👀

User Image MarketNinja Posted - 10 hours ago

$NVAX good news with an updated JJ 1 vaccine. Here we come under $4 ...

User Image DrSammy Posted - 10 hours ago

$NVAX Good news is that they released manufacturing of the monovalent JN.1 vaccine on the same day as WHO recommendation/selection announcement! WHO: "As the virus is expected to continue to evolve from JN.1, the TAG-CO-VAC advises the use of a monovalent JN.1 lineage as the antigen in future formulations of COVID-19 vaccines." Novavax : "JN.1 vaccine candidate induces neutralization responses to JN.1, JN.4, JN.1.11.1, JN.1.7, JN.1.13.1 and JN.1.16 strains." As Nova's Rick Crowley stated before: ".. COVID is a very different animal than flu. And so the evolution of the strain changes is more rapid. I think the only way any vaccine manufacturer can keep up with that is to manufacture variance of interest at risk and have a stockpile. https://www.who.int/news/item/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines

User Image BTC321 Posted - 10 hours ago

$NVAX https://x.com/novavax/status/1783930802092327069?s=46&t=X6qO3UejysWvD0UxMTsJrA

User Image HardToLove Posted - 10 hours ago

$NVAX As usual, good news starts SP tanking. Off $4.13 HOD now $4.07

User Image DonCorleone77 Posted - 10 hours ago

$NVAX Novavax prepared to deliver JN.1 COVID vaccine in line with WHO recommendation The World Health Organization's Technical Advisory Group on COVID-19 Vaccine Composition recommended the use of a monovalent JN.1 lineage COVID-19 vaccine as one approach to address the ongoing SARS-CoV-2 virus evolution, which is expected to lead to circulation of additional JN.1 descendant strains, Novavax stated. Novavax plans to be ready to deliver our JN.1 protein-based non-mRNA COVID-19 vaccine globally this fall. We have been developing and manufacturing this vaccine candidate at risk and are well positioned for the upcoming vaccination season, the company said.

Analyst Ratings
HC Wainwright & Co. Buy Mar 1, 24
HC Wainwright & Co. Buy Aug 10, 23
B. Riley Securities Buy Aug 9, 23
HC Wainwright & Co. Buy May 10, 23
B. Riley Securities Neutral Mar 1, 23
HC Wainwright & Co. Buy Feb 13, 23
HC Wainwright & Co. Buy Jan 2, 23
B. Riley Securities Buy Oct 14, 22
JP Morgan Underweight Sep 22, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dubovsky Filip President, R&D President, R&D Dec 14 Option 5.69 2,833 16,120 55,150 12/18/23
Dubovsky Filip President, R&D President, R&D Nov 05 Option 7.06 1,400 9,884 52,994 11/07/23
Dubovsky Filip President, R&D President, R&D Sep 16 Option 7.71 12,644 97,485 57,702 09/19/23
Trizzino John EVP, CCO and CBO EVP, CCO and CBO Mar 10 Option 6.52 4,609 30,051 11,531 03/14/23
Kelly James Patrick EVP, CFO and Treasur.. EVP, CFO and Treasurer Mar 10 Option 6.52 4,609 30,051 5,832 03/14/23
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Mar 10 Option 6.52 4,609 30,051 13,058 03/14/23
Glenn Gregory M President, R&D President, R&D Mar 06 Buy 7.01 6,000 42,060 14,473 03/14/23
Glenn Gregory M President, R&D President, R&D Mar 06 Option 6.52 6,298 41,063 20,771 03/14/23
YOUNG JAMES F Director Director Mar 31 Sell 74.21 12,500 927,625 62,590 04/04/22
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Sell 197.3 5,000 986,500 2,760 12/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Option 19.08 5,000 95,400 7,760 12/03/21
Glenn Gregory M President, R&D President, R&D Nov 23 Option 19.08 8,250 157,410 12,311 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 23 Sell 200.02 8,250 1,650,165 4,061 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 02 Option 19.08 8,250 157,410 12,311 11/04/21
Glenn Gregory M President, R&D President, R&D Nov 02 Sell 186.83 8,250 1,541,348 4,061 11/04/21
Glenn Gregory M President, R&D President, R&D Oct 26 Option 10.33 11,712 120,985 5,439 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 26 Sell 132.97 10,334 1,374,112 4,061 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 19 Option 19.08 8,250 157,410 12,311 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 19 Sell 166.54 8,250 1,373,955 4,061 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 12 Option 19.08 8,250 157,410 12,311 10/14/21
Glenn Gregory M President, R&D President, R&D Oct 12 Sell 164.07 8,250 1,353,578 4,061 10/14/21
Glenn Gregory M President, R&D President, R&D Jun 17 Option 22.5 10,535 237,038 7,630 06/17/21
Glenn Gregory M President, R&D President, R&D Jun 17 Sell 191.31 8,127 1,554,776 2,811 06/17/21
Glenn Gregory M President, R&D President, R&D Apr 19 Option 61.73 10,531 650,079 7,630 04/19/21
MCMANUS MICHAEL A JR Director Director Mar 23 Sell 220.99 4,000 883,960 5,951 03/23/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Option 21.38 3,404 72,778 670 03/09/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Sell 163.31 3,211 524,388 287 03/09/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Option 26.71 15,022 401,238 15,297 02/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Sell 241.28 15,022 3,624,508 275 02/03/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Option 23.25 13,756 319,827 1,436 01/07/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Sell 114.35 17,913 2,048,352 287 01/07/21
Erck Stanley C President and CEO President and CEO Nov 18 Sell 90.33 52,316 4,725,704 20,495 11/18/20
Erck Stanley C President and CEO President and CEO Nov 18 Option 32.7 52,317 1,710,766 72,811 11/18/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Oct 01 Sell 111.32 2,250 250,470 5,087 10/01/20
Erck Stanley C President and CEO President and CEO Oct 01 Sell 111.71 12,233 1,366,548 20,494 10/01/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Option 5.95 24,750 147,262 43,054 09/30/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Sell 110.91 42,779 4,744,618 275 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Option 5.95 25,000 148,750 46,510 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Sell 110.91 44,949 4,985,295 1,561 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Option 5.95 29,600 176,120 53,008 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Sell 110.86 43,321 4,802,567 7,337 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Option 5.95 50,000 297,500 74,606 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Sell 110.91 29,112 3,228,813 32,727 09/30/20